Atypical antipsychotics in the treatment of patients with a dual diagnosis of schizophrenia spectrum disorders and substance use disorders: the results of a randomized comparative study.

Skryabin, V Yu; Vinnikova, M A; Ezhkova, E V; Titkov, M S; Bulatova, R A

Skryabin, V Yu; Vinnikova, M A; Ezhkova, E V; Titkov, M S; Bulatova, R A.

Affiliation

Skryabin VY; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.
Vinnikova MA; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia.
Ezhkova EV; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.
Titkov MS; Scientific Department, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
Bulatova RA; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.

J Addict Dis ; 39(4): 513-525, 2021.

Article in En | MEDLINE | ID: mdl-33832406

Subject(s)
Key words

BPRS; PANSS; Schizophrenia; VAS; atypical antipsychotics; craving; dual diagnosis; substance use disorders

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Diagnosis, Dual (Psychiatry) / Substance-Related Disorders / Quetiapine Fumarate / Aripiprazole / Haloperidol Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: J Addict Dis Journal subject: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Year: 2021 Document type: Article Affiliation country: Rusia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google